Diseases/Conditions News Headlines - Yahoo! News

http://news.yahoo.com/diseases/ Get the latest Diseases/Conditions news headlines from Yahoo! News. Find breaking Diseases/Conditions news, including analysis and opinion on top Diseases/Conditions stories, photos and more.en-USCopyright (c) 2012 Yahoo! Inc. All rights reservedThu, 25 Oct 2012 18:10:00 -04005http://news.yahoo.com/diseases/ http://l.yimg.com/a/i/us/nws/th/main_142c.gif<p><a href="http://news.yahoo.com/first-person-husband-helped-breast-cancers-darkest-hours-221000883.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ONlddjqgxtsVWpw27V_vww--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/associatedcontent/470_2528118.jpg" width="130" height="86" alt="First Person: How My Husband Helped Me Through Breast Cancer&#039;s Darkest Hours" align="left" title="First Person: How My Husband Helped Me Through Breast Cancer&#039;s Darkest Hours" border="0" /></a>October is Breast Cancer Awareness Month. Yahoo News asked women who have had breast cancer or are going through treatment to write about the people in their lives who stood by them and cared for them. Here&#039;s one story.</p><br clear="all"/>http://news.yahoo.com/first-person-husband-helped-breast-cancers-darkest-hours-221000883.htmlThu, 25 Oct 2012 18:10:00 -0400Yahoo! Contributor Networkfirst-person-husband-helped-breast-cancers-darkest-hours-221000883<p><a href="http://news.yahoo.com/first-person-husband-helped-breast-cancers-darkest-hours-221000883.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ONlddjqgxtsVWpw27V_vww--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/associatedcontent/470_2528118.jpg" width="130" height="86" alt="First Person: How My Husband Helped Me Through Breast Cancer&#039;s Darkest Hours" align="left" title="First Person: How My Husband Helped Me Through Breast Cancer&#039;s Darkest Hours" border="0" /></a>October is Breast Cancer Awareness Month. Yahoo News asked women who have had breast cancer or are going through treatment to write about the people in their lives who stood by them and cared for them. Here&#039;s one story.</p><br clear="all"/>Researchers on three unrelated projects have published results suggesting that certain traits in patients with Crohn's disease are related to race. Experts predict that their conclusions will aid in the development of personalized treatment for this incurable digestive disease.http://news.yahoo.com/scientists-discover-traits-tied-race-crohns-disease-213300315.htmlThu, 25 Oct 2012 17:33:00 -0400Yahoo! Contributor Networkscientists-discover-traits-tied-race-crohns-disease-213300315<p><a href="http://news.yahoo.com/first-person-best-friend-helped-breast-cancer-213200949.html"><img src="http://l3.yimg.com/bt/api/res/1.2/cuj7ZlpTrlGm65q4JanFzw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/associatedcontent/470_2528505.jpg" width="130" height="86" alt="First Person: How My Best Friend Helped Me Through Breast Cancer" align="left" title="First Person: How My Best Friend Helped Me Through Breast Cancer" border="0" /></a>October is Breast Cancer Awareness Month. Yahoo News asked women who have had breast cancer or are going through treatment to write about the people in their lives who stood by them and cared for them. Here&#039;s one story.</p><br clear="all"/>http://news.yahoo.com/first-person-best-friend-helped-breast-cancer-213200949.htmlThu, 25 Oct 2012 17:32:00 -0400Yahoo! Contributor Networkfirst-person-best-friend-helped-breast-cancer-213200949<p><a href="http://news.yahoo.com/first-person-best-friend-helped-breast-cancer-213200949.html"><img src="http://l3.yimg.com/bt/api/res/1.2/cuj7ZlpTrlGm65q4JanFzw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/associatedcontent/470_2528505.jpg" width="130" height="86" alt="First Person: How My Best Friend Helped Me Through Breast Cancer" align="left" title="First Person: How My Best Friend Helped Me Through Breast Cancer" border="0" /></a>October is Breast Cancer Awareness Month. Yahoo News asked women who have had breast cancer or are going through treatment to write about the people in their lives who stood by them and cared for them. Here&#039;s one story.</p><br clear="all"/>NEW YORK (Reuters Health) - There's no shortage of websites with information on prostate cancer treatment, but they may be well beyond the average person's comprehension, a new study finds. The study, of 62 such websites, found that only three had treatment information written below a 9th-grade reading level. Most often, sites aimed for the reading level of a high school senior - far beyond the reading skills of many Americans. That's a worry, researchers say, because there is a range of treatment options for prostate cancer. ...http://news.yahoo.com/prostate-cancer-tough-understand-191112942.htmlThu, 25 Oct 2012 15:11:12 -0400Reutersprostate-cancer-tough-understand-191112942NEW YORK (Reuters Health) - Leg amputations in older people whose arteries are clogged by cholesterol buildups have gone down over the past decade, according to a new U.S. study. But thousands of people with diseased blood vessels in their legs still lose a leg or part of one every year - a number researchers say is higher than it should be. "Our real goal is to highlight the fact that there are still a lot of amputations occurring around the country," said Dr. W. Schuyler Jones, a cardiologist at Duke University Medical Center in Durham, North Carolina. ...http://news.yahoo.com/leg-amputations-artery-disease-decline-184720365.htmlThu, 25 Oct 2012 14:47:20 -0400Reutersleg-amputations-artery-disease-decline-184720365<p><a href="http://news.yahoo.com/germany-orders-recall-novartis-flu-shots-142502789--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/2rvbtL34wY.QVAhSDW9GJw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/28ef352a14d9f81e1e0f6a7067007cc9.jpg" width="130" height="86" alt="FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. Novartis AG on Thursday, Oct. 25, 2012, reported a net profit of $2.48 billion during the third quarter, with income remaining flat as new drugs offset patent expirations. The Basel-based company&#039;s profits between July and September were virtually unchanged from $2.49 billion in the third quarter of 2011. (AP Photo/Keystone, Georgios Kefalas, File)." align="left" title="FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. Novartis AG on Thursday, Oct. 25, 2012, reported a net profit of $2.48 billion during the third quarter, with income remaining flat as new drugs offset patent expirations. The Basel-based company&#039;s profits between July and September were virtually unchanged from $2.49 billion in the third quarter of 2011. (AP Photo/Keystone, Georgios Kefalas, File)." border="0" /></a>German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.</p><br clear="all"/>http://news.yahoo.com/germany-orders-recall-novartis-flu-shots-142502789--finance.htmlThu, 25 Oct 2012 14:31:56 -0400Associated Pressgermany-orders-recall-novartis-flu-shots-142502789--finance<p><a href="http://news.yahoo.com/germany-orders-recall-novartis-flu-shots-142502789--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/2rvbtL34wY.QVAhSDW9GJw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/28ef352a14d9f81e1e0f6a7067007cc9.jpg" width="130" height="86" alt="FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. Novartis AG on Thursday, Oct. 25, 2012, reported a net profit of $2.48 billion during the third quarter, with income remaining flat as new drugs offset patent expirations. The Basel-based company&#039;s profits between July and September were virtually unchanged from $2.49 billion in the third quarter of 2011. (AP Photo/Keystone, Georgios Kefalas, File)." align="left" title="FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. Novartis AG on Thursday, Oct. 25, 2012, reported a net profit of $2.48 billion during the third quarter, with income remaining flat as new drugs offset patent expirations. The Basel-based company&#039;s profits between July and September were virtually unchanged from $2.49 billion in the third quarter of 2011. (AP Photo/Keystone, Georgios Kefalas, File)." border="0" /></a>German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.</p><br clear="all"/>MADRID (Reuters) - Spain joined other European countries in halting the sale of anti-influenza vaccines made by Swiss group Novartis, after small particles were found in some of the injections. Spain will halt the sale of all the Chiromas and Chiroflu vaccines, produced by Novartis in Italy, the Spanish Medicines and Health Products Agency (AEMPS) said in a statement on Thursday. Spain follows Italy, where the sale and use of four anti-flu vaccines produced by Novartis was banned on Wednesday pending tests for possible side effects after white floating material was discovered in some vaccines. ...http://news.yahoo.com/spain-regulator-halts-sale-novartis-flu-vaccines-165837847--finance.htmlThu, 25 Oct 2012 12:58:37 -0400Reutersspain-regulator-halts-sale-novartis-flu-vaccines-165837847--finance<p><a href="http://news.yahoo.com/novartis-says-confident-flu-vaccines-produced-italy-safe-041029630--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/8xdh24SnPDCMwW6uAjEIkQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-25T041029Z_1_CBRE89O0BLM00_RTROPTP_2_NOVARTIS.JPG" width="130" height="86" alt="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" align="left" title="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" border="0" /></a>ZURICH (Reuters) - Swiss drugmaker Novartis said flu vaccines that Italy has banned from sale are safe and it does not expect other countries to take similar action. Italy banned four anti-influenza vaccines produced by Novartis on Wednesday pending tests for possible side effects after small particles were found in some of the injections. Chief executive Joseph Jimenez defended the vaccines on Thursday after Novartis reported third-quarter sales that missed forecasts, as the strong dollar and the loss of its U.S. patent for top-selling blood pressure drug Diovan took a toll. ...</p><br clear="all"/>http://news.yahoo.com/novartis-says-confident-flu-vaccines-produced-italy-safe-041029630--finance.htmlThu, 25 Oct 2012 12:15:35 -0400Reutersnovartis-says-confident-flu-vaccines-produced-italy-safe-041029630--finance<p><a href="http://news.yahoo.com/novartis-says-confident-flu-vaccines-produced-italy-safe-041029630--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/8xdh24SnPDCMwW6uAjEIkQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-25T041029Z_1_CBRE89O0BLM00_RTROPTP_2_NOVARTIS.JPG" width="130" height="86" alt="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" align="left" title="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" border="0" /></a>ZURICH (Reuters) - Swiss drugmaker Novartis said flu vaccines that Italy has banned from sale are safe and it does not expect other countries to take similar action. Italy banned four anti-influenza vaccines produced by Novartis on Wednesday pending tests for possible side effects after small particles were found in some of the injections. Chief executive Joseph Jimenez defended the vaccines on Thursday after Novartis reported third-quarter sales that missed forecasts, as the strong dollar and the loss of its U.S. patent for top-selling blood pressure drug Diovan took a toll. ...</p><br clear="all"/>FRANKFURT (Reuters) - Germany's vaccination agency said on Thursday that some anti-influenza vaccines produced by Novartis should not be used and that the Swiss drugmaker had agreed to recall them. The Paul-Ehrlich Institute said some lots of flu vaccines Begripal and Fluad would be recalled. Italy on Wednesday banned the sale and use of anti-influenza vaccines produced by Novartis pending tests for possible side effects after small particles were found in some of the injections, prompting authorities in Switzerland to also take precautionary steps. ...http://news.yahoo.com/german-regulator-recalls-novartis-flu-vaccines-141402482--finance.htmlThu, 25 Oct 2012 10:14:02 -0400Reutersgerman-regulator-recalls-novartis-flu-vaccines-141402482--financeZURICH (Reuters) - The Chief Executive of Swiss drugmaker Novartis is confident its flu vaccines manufactured in Italy are safe and does not expect further countries to ban sales or halt deliveries. In a conference call to journalists, Chief Executive Joseph Jimenez said Novartis shipped the two vaccines produced in Italy to European markets and parts of Asia. He said he did not expect other countries to take action to suspend deliveries but he could not rule this out. Novartis reported worse-than-expected third quarter sales on Thursday, dragged down by the loss of a U.S. ...http://news.yahoo.com/novartis-does-not-expect-further-sales-bans-flu-061011730--finance.htmlThu, 25 Oct 2012 02:10:11 -0400Reutersnovartis-does-not-expect-further-sales-bans-flu-061011730--finance(Reuters) - At least two thirds of people with advanced cancer believed the chemotherapy they were receiving might cure them, even though the treatment was only being given to buy some time or make them comfortable, according to a U.S. survey. Researchers reported in the New England Journal of Medicine that 69 percent of patients who were terminally ill with lung cancer, and 81 percent with fatal colorectal cancer, did not understand that their chemotherapy was not at all likely to eliminate their tumors. ...http://news.yahoo.com/study-cancer-patients-hopes-chemo-too-high-022102496.htmlWed, 24 Oct 2012 22:21:02 -0400Reutersstudy-cancer-patients-hopes-chemo-too-high-022102496CHICAGO (Reuters) - The latest data from a long-running study of hormone therapy suggests women who started taking hormone replacements within five years of menopause were 30 percent less likely to develop Alzheimer's disease than women who started years later. The findings, reported on Wednesday in the journal Neurology, add to evidence suggesting that taking hormone treatments around the time of menopause may be doing more than just helping women cope with hot flashes and night sweats. ...http://news.yahoo.com/hormone-therapy-may-cut-alzheimers-risk-menopausal-women-234043535--finance.htmlWed, 24 Oct 2012 19:40:43 -0400Reutershormone-therapy-may-cut-alzheimers-risk-menopausal-women-234043535--financeMost patients getting chemotherapy for incurable lung or colon cancers mistakenly believe that the treatment can cure them rather than just buy them some more time or ease their symptoms, a major study suggests. Researchers say doctors either are not being honest enough with patients or people are in denial that they have a terminal disease.http://news.yahoo.com/study-cancer-patients-overestimate-value-chemo-211451867.htmlWed, 24 Oct 2012 17:14:51 -0400Associated Pressstudy-cancer-patients-overestimate-value-chemo-211451867NEW YORK (Reuters Health) - An arsenal of hand sanitizers, hygiene education and good old-fashioned soap failed to prevent asthma attacks among school children in one Alabama county. For children with asthma, the common cold is the top trigger of symptom attacks. So in theory, cleaner hands at school could mean fewer colds being passed around - and fewer asthma attacks. But in a new clinical trial, researchers found that kids at schools with a "hand hygiene" plan, including alcohol-based hand sanitizers, suffered asthma attacks just often as their peers at other schools. ...http://news.yahoo.com/school-hand-hygiene-plan-shows-no-asthma-benefit-210823019.htmlWed, 24 Oct 2012 17:08:23 -0400Reutersschool-hand-hygiene-plan-shows-no-asthma-benefit-210823019<p><a href="http://news.yahoo.com/cancer-patients-hopes-chemo-too-high-210716403.html"><img src="http://l1.yimg.com/bt/api/res/1.2/e8G4I6OprwGRBqinCOcYjQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-25T022825Z_2_CBRE89O009100_RTROPTP_2_FRANCE.JPG" width="130" height="86" alt="A patient receives chemotherapy treatment for breast cancer in a file photo. REUTERS/Eric Gaillard" align="left" title="A patient receives chemotherapy treatment for breast cancer in a file photo. REUTERS/Eric Gaillard" border="0" /></a>NEW YORK (Reuters Health) - At least two thirds of people with advanced cancer in a new survey believed the chemotherapy they&#039;re receiving might cure them, even though the treatment is only being given to buy some time or make them comfortable. &quot;Their expectations are way out of line with reality,&quot; Dr. Deborah Schrag of the Dana-Farber Cancer Institute in Boston told Reuters Health. ...</p><br clear="all"/>http://news.yahoo.com/cancer-patients-hopes-chemo-too-high-210716403.htmlWed, 24 Oct 2012 17:07:16 -0400Reuterscancer-patients-hopes-chemo-too-high-210716403<p><a href="http://news.yahoo.com/cancer-patients-hopes-chemo-too-high-210716403.html"><img src="http://l1.yimg.com/bt/api/res/1.2/e8G4I6OprwGRBqinCOcYjQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-25T022825Z_2_CBRE89O009100_RTROPTP_2_FRANCE.JPG" width="130" height="86" alt="A patient receives chemotherapy treatment for breast cancer in a file photo. REUTERS/Eric Gaillard" align="left" title="A patient receives chemotherapy treatment for breast cancer in a file photo. REUTERS/Eric Gaillard" border="0" /></a>NEW YORK (Reuters Health) - At least two thirds of people with advanced cancer in a new survey believed the chemotherapy they&#039;re receiving might cure them, even though the treatment is only being given to buy some time or make them comfortable. &quot;Their expectations are way out of line with reality,&quot; Dr. Deborah Schrag of the Dana-Farber Cancer Institute in Boston told Reuters Health. ...</p><br clear="all"/>Federal regulators say a pilot study of cancer risks posed to residents near seven nuclear power sites in the United States will update 22-year-old data, but an industry group says the study won't come up with anything new.http://news.yahoo.com/cancer-risks-studied-near-7-us-nuclear-sites-172755786.htmlWed, 24 Oct 2012 14:08:21 -0400Associated Presscancer-risks-studied-near-7-us-nuclear-sites-172755786<p><a href="http://news.yahoo.com/italy-bans-novartis-flu-vaccines-pending-tests-104210024--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/qVA6ZYkT8xNS16uODqEDBg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-24T131806Z_1_CBRE89N10Y900_RTROPTP_2_NOVARTIS.JPG" width="130" height="86" alt="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" align="left" title="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" border="0" /></a>ROME/ZURICH (Reuters) - Italy banned the sale and use of anti-influenza vaccines produced by Novartis on Wednesday pending tests for possible side effects, prompting authorities in Switzerland to also take precautionary steps. The Italian Health Ministry advised citizens not to buy or use the drugs Agrippal, Fluad, subunit Influpozzi and adjunvated Influpozzi until further notice. It said 487,738 vaccine doses were affected, and the move came after the Italian Pharmaceutical Agency decided further tests on the products may be necessary following indications of possible side effects. ...</p><br clear="all"/>http://news.yahoo.com/italy-bans-novartis-flu-vaccines-pending-tests-104210024--finance.htmlWed, 24 Oct 2012 13:15:17 -0400Reutersitaly-bans-novartis-flu-vaccines-pending-tests-104210024--finance<p><a href="http://news.yahoo.com/italy-bans-novartis-flu-vaccines-pending-tests-104210024--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/qVA6ZYkT8xNS16uODqEDBg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-24T131806Z_1_CBRE89N10Y900_RTROPTP_2_NOVARTIS.JPG" width="130" height="86" alt="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" align="left" title="A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel" border="0" /></a>ROME/ZURICH (Reuters) - Italy banned the sale and use of anti-influenza vaccines produced by Novartis on Wednesday pending tests for possible side effects, prompting authorities in Switzerland to also take precautionary steps. The Italian Health Ministry advised citizens not to buy or use the drugs Agrippal, Fluad, subunit Influpozzi and adjunvated Influpozzi until further notice. It said 487,738 vaccine doses were affected, and the move came after the Italian Pharmaceutical Agency decided further tests on the products may be necessary following indications of possible side effects. ...</p><br clear="all"/>(Reuters) - European health regulators granted conditional approval to Pfizer Inc's Xalkori to treat advanced non-small cell lung cancer in patients with a specific genetic mutation, the company said on Wednesday. The approval had been expected after the European Medicines Agency in July recommended the drug for conditional authorization, which means Pfizer must still submit further data from a recent successful trial. Conditional marketing authorization in Europe is granted to medicines that address unmet medical needs and whose availability would result in a significant public health ...http://news.yahoo.com/pfizer-lung-cancer-drug-gets-conditional-eu-approval-153313830--finance.htmlWed, 24 Oct 2012 11:33:13 -0400Reuterspfizer-lung-cancer-drug-gets-conditional-eu-approval-153313830--financeTexas put $3 billion on the table to prove it was serious about fighting cancer, but it will take more than money to convince scientists that's still the case.http://news.yahoo.com/answers-sought-3b-texas-cancer-agency-meets-071922070--finance.htmlWed, 24 Oct 2012 10:53:23 -0400Associated Pressanswers-sought-3b-texas-cancer-agency-meets-071922070--financeNEW YORK (Reuters Health) - People with chronic dry mouth related to cancer treatment reported some improvement in symptoms like sticky saliva and dry lips after eight weeks of group acupuncture, in a new study from the UK. It's not clear how much of that benefit could have been a result of patients' expectations that acupuncture would help them or the effect of a therapeutic relationship with their acupuncturist - rather than the actual needles - researchers said. The study's lead author said more work is needed to answer those questions. ...http://news.yahoo.com/acupuncture-may-ease-dry-mouth-cancer-123903391.htmlWed, 24 Oct 2012 08:39:03 -0400Reutersacupuncture-may-ease-dry-mouth-cancer-123903391It?s that time of year, again: flu season. We?ve all had it. We have vaccines to prevent the flu, antivirals to help alleviate suffering, and control measures like hand washing and social distancing to reduce transmission. But, for a disease that hits every year, influenza retains many mysteries.http://news.yahoo.com/flu-near-finally-way-track-avoid-getting-sick-122644961.htmlWed, 24 Oct 2012 08:26:44 -0400Takepart.comflu-near-finally-way-track-avoid-getting-sick-122644961<p><a href="http://news.yahoo.com/israeli-medical-device-offers-alzheimers-treatment-114454957--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/8G2wQuhk6cKLfjllTtgURQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-24T162623Z_1_CBRE89N19O100_RTROPTP_2_NEURONIX-ALZHEIMERS.JPG" width="130" height="86" alt="Neuronix CEO Eyal Baror poses for a photo next to a newly-developed device to treat Alzheimer&#039;s disease at Assaf Harofeh Medical Center near Tel Aviv" align="left" title="Neuronix CEO Eyal Baror poses for a photo next to a newly-developed device to treat Alzheimer&#039;s disease at Assaf Harofeh Medical Center near Tel Aviv" border="0" /></a>TEL AVIV (Reuters) - Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer&#039;s disease, expects the system to be approved by the U.S. Food &amp; Drug Administration in late 2014. The device, which combines electromagnetic stimulation with computer-based cognitive training, is already approved for use in Europe, Israel and several Asian countries such as Singapore. &quot;You stimulate the brain on a biological level as well as on a cognitive level,&quot; Neuronix CEO Eyal Baror told Reuters, saying this double approach created longer-lasting benefits. ...</p><br clear="all"/>http://news.yahoo.com/israeli-medical-device-offers-alzheimers-treatment-114454957--finance.htmlWed, 24 Oct 2012 08:05:37 -0400Reutersisraeli-medical-device-offers-alzheimers-treatment-114454957--finance<p><a href="http://news.yahoo.com/israeli-medical-device-offers-alzheimers-treatment-114454957--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/8G2wQuhk6cKLfjllTtgURQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-10-24T162623Z_1_CBRE89N19O100_RTROPTP_2_NEURONIX-ALZHEIMERS.JPG" width="130" height="86" alt="Neuronix CEO Eyal Baror poses for a photo next to a newly-developed device to treat Alzheimer&#039;s disease at Assaf Harofeh Medical Center near Tel Aviv" align="left" title="Neuronix CEO Eyal Baror poses for a photo next to a newly-developed device to treat Alzheimer&#039;s disease at Assaf Harofeh Medical Center near Tel Aviv" border="0" /></a>TEL AVIV (Reuters) - Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer&#039;s disease, expects the system to be approved by the U.S. Food &amp; Drug Administration in late 2014. The device, which combines electromagnetic stimulation with computer-based cognitive training, is already approved for use in Europe, Israel and several Asian countries such as Singapore. &quot;You stimulate the brain on a biological level as well as on a cognitive level,&quot; Neuronix CEO Eyal Baror told Reuters, saying this double approach created longer-lasting benefits. ...</p><br clear="all"/>DUBLIN (Reuters) - Irish drugmaker Elan Corp Plc said third-quarter revenue rose by 10 percent as sales of its multiple sclerosis (MS) drug grew. Tysabri sales, the blockbuster multiple sclerosis drug it co-markets with Biogen Idec, grew 3 percent to $403.8 million, while the number of patients rose 13 percent. Elan relies on Tysabri for the bulk of its earnings following the failure of bapineuzumab, one of the most anticipated experimental drugs for Alzheimer's disease being developed with Johnson & Johnson and Pfizer. Elan said third-quarter revenue rose to $306.6 million from $279. ...http://news.yahoo.com/elan-track-multiple-sclerosis-drug-sales-rise-065727899.htmlWed, 24 Oct 2012 02:57:27 -0400Reuterselan-track-multiple-sclerosis-drug-sales-rise-065727899<p><a href="http://news.yahoo.com/1-1-000-men-battles-breast-cancer-214324187--abc-news-health.html"><img src="http://l2.yimg.com/bt/api/res/1.2/Y1Q0ShoQXPqaNtq42Jz3HQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/gma/us.abcnews.gma.com/zp_cecil_herrin_jef_121019_wmain.jpg" width="130" height="86" alt="Men Ignore Early Signs of Breast Cancer" align="left" title="Men Ignore Early Signs of Breast Cancer" border="0" /></a>Disease Kills One American Man Daily, Researchers Say</p><br clear="all"/>http://news.yahoo.com/1-1-000-men-battles-breast-cancer-214324187--abc-news-health.htmlTue, 23 Oct 2012 17:43:24 -0400Good Morning America1-1-000-men-battles-breast-cancer-214324187--abc-news-health<p><a href="http://news.yahoo.com/1-1-000-men-battles-breast-cancer-214324187--abc-news-health.html"><img src="http://l2.yimg.com/bt/api/res/1.2/Y1Q0ShoQXPqaNtq42Jz3HQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/gma/us.abcnews.gma.com/zp_cecil_herrin_jef_121019_wmain.jpg" width="130" height="86" alt="Men Ignore Early Signs of Breast Cancer" align="left" title="Men Ignore Early Signs of Breast Cancer" border="0" /></a>Disease Kills One American Man Daily, Researchers Say</p><br clear="all"/>NEW YORK (Reuters Health) - Older women who regularly drink green tea may have slightly lower risks of colon, stomach and throat cancers than women who make no time for tea, a large study suggests. Researchers found that of more than 69,000 Chinese women followed for a decade, those who drank green tea at least three times a week were 14 percent less likely to develop a cancer of the digestive system. That mainly meant lower odds of colon, stomach and esophageal cancers. No one can say whether green tea, itself, is the reason. Green-tea lovers are often more health-conscious in general. ...http://news.yahoo.com/green-tea-drinkers-show-lower-cancer-risks-205817303.htmlTue, 23 Oct 2012 16:58:17 -0400Reutersgreen-tea-drinkers-show-lower-cancer-risks-205817303

Source: http://rss.news.yahoo.com/rss/diseases

dalai lama tamera mowry slow jam the news madden cover obama slow jams the news metta world peace ron artest